Trials / Unknown
UnknownNCT04247854
Probiotics Pilot Project
Probiotic Bacillus for Decolonization of Methicillin-resistant Staphylococcus Aureus (MRSA) in Patients Undergoing Total Joint Arthroplasty: A Randomized, Prospective, Placebo-Controlled Pilot Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Rothman Institute Orthopaedics · Academic / Other
- Sex
- —
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This pilot study is designed to determine if ingestion of Bacillus probiotics can cause alteration in levels of S. aureus colonization in the nose and intestine in preoperative orthopedic patients undergoing elective primary TJA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Bacillus subtilis probiotic | Bacillus probiotic which contains one confidential ingredient of Bacillus subtilis spores (2 x 1010 CFU/g). Over 5 days of interventional period, the patient receives one tablet (250 mg; 5 x 109 CFU) of probiotic per day. |
| OTHER | Placebo | Over 5 days of interventional period, the patient receives 1 placebo tablet per day |
Timeline
- Start date
- 2020-02-12
- Primary completion
- 2021-01-22
- Completion
- 2021-01-22
- First posted
- 2020-01-30
- Last updated
- 2020-02-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04247854. Inclusion in this directory is not an endorsement.